Phase 1 IPF Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
Mannkind Corporation24 enrolled8 locationsNCT07344558
Recruiting
Phase 1
A Phase Ia Clinical Trial of HW241045
Healthy VolunteersIPF
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.56 enrolled1 locationNCT07448194
Recruiting
Phase 1
Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
IPF
Agomab Spain S.L.145 enrolled1 locationNCT06181370
Completed
Phase 1
Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties of DWN12088 following Oral Administration in Healthy Volunteers
Idiopathic Pulmonary Fibrosis (IPF)
Daewoong Pharmaceutical Co., Ltd.80 enrolled1 locationACTRN12619001239156